Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients

European Journal of Neurology

Volumn 9, Issue 4, 2002, Pages 413-418

  Miljkovic, Dj ^a   Drulovic, J ^b   Trajkovic, V ^c   Mesaros, S ^b   Dujmovic, I ^b   Maksimovic, D ^a   Samardzic, T ^a   Stojsavljevic, N ^b   Levic, Z ^b   Mostarica Stojkovic, M ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cerebrospinal fluid; Interleukin 6; Multiple sclerosis; Nitric oxide

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PATHOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NITRATES; NITRIC OXIDE; NITRITES;

EID: 0036042663     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00437.x     Document Type: Article

References (36)

1. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α
2. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
3. Multiple extracellular signals are required for long-term oligodendrocyte survival
4. Induction and regulation of interleukin-6 gene expression in rat astrocytes
5. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
6. The multiplex function of nitric oxide in (auto) immunity
7. Peroxynitrite formation within the central nervous system in active multiple sclerosis
8. The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma
9. Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: No correlation with disease activity
10. Interleukin-6 is elevated in plasma in multiple sclerosis
11. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation
12. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis
13. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels
14. Bacterial lipopolysaccharide increases interleukin-6 and prostaglandin release in rat cortical type I astrocytes by different mechanisms: Role of anti-inflammatory agents
15. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6
16. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines
17. Evidence for increased nitric oxide production in multiple sclerosis
18. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
19. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: A paracrine mechanism potentially enhancing neuronal survival
20. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
21. IL-6 detection in multiple sclerosis brain
22. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans
23. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis
24. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
25. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
26. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
27. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis
28. Interleukin-6 expression in human multiple sclerosis lesions
29. Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6
30. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of NFκB nuclear protein
31. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells
32. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages
33. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
34. IL-6 and APPs: Anti-inflammatory and immunosupressive mediators
35. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
36. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hibridization